Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Commentary: Let the Time Fly: Dopamine is the Arbiter
Volume: 17 Issue: 1
Author(s): Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* Ti-Fei Yuan*
Affiliation:
- Trastornos del Movimiento y Sueno, Hospital General Dr. Manuel Gea Gonzalez, Ciudad de Mexico,Mexico
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai,China
Export Options
About this article
Cite this article as:
Liu Xiaodong, Zhang Changzheng, Arias-Carrion Oscar *, Yuan Ti-Fei *, Commentary: Let the Time Fly: Dopamine is the Arbiter, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/1871527316999170505110106
DOI https://dx.doi.org/10.2174/1871527316999170505110106 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)
Current Drug Targets - Cardiovascular & Hematological Disorders α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia
Current Pharmaceutical Design Melatonin Ameliorates BPA Induced Oxidative Stress in Human Red Blood Cells: An <i>In vitro</i> Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Cognitive - Behavioral Therapy in Central Sensitivity Syndromes
Current Rheumatology Reviews The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use
CNS & Neurological Disorders - Drug Targets Advancing Drug Therapy for Brain Tumours: A Current Review of the Pro-inflammatory Peptide Substance P and its Antagonists as Anti-cancer Agents
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member:
Current Drug Targets Meet Our Editorial Board Member:
Current Alzheimer Research Repetitive Transcranial Magnetic Stimulation Reverses Aβ1–42-induced Dysfunction in Gamma Oscillation during Working Memory
Current Alzheimer Research ACKNOWLEDGEMENTS TO REVIEWERS
Central Nervous System Agents in Medicinal Chemistry HIV Genetic Diversity: Biological and Public Health Consequences
Current HIV Research Neuregulin Signaling in Pieces-Evolution of the Gene Family
Current Pharmaceutical Design Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma
Current Respiratory Medicine Reviews Tin as an Emerging Surrogate for Lead-free Perovskite Solar Cells
Nanoscience & Nanotechnology-Asia Inflammatory Biomarkers in AD: Implications for Diagnosis
Current Alzheimer Research Metabolic Changes in Autoimmune Diseases
Current Drug Discovery Technologies Meet Our Co-Editor
Current Psychopharmacology Managing the Suicidal Risk in Pregnant Women with Severe and Persistent Psychiatric Disorder: Focus on Antisuicidal Drugs and Somatic Interventions
Current Psychiatry Reviews Cannabis use and Duration of Untreated Psychosis: A Systematic Review and Meta-Analysis
Current Pharmaceutical Design